Clinical Trial

Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

Study acronym: PRE-EMPT

Withdrawn Phase 2

View on ClinicalTrials.gov →

Why the trial stopped

This is temporary withdrawal as the record was started too soon. It will be reactivated in near future.

Summary

PRE-EMPT will assemble a study group of 150 civilian and Veteran participants from three populations (low risk, intermediate risk, and high risk for self-harm). The investigators will obtain clinical assessments, MRI, and blood levels for circular RNA (circRNA). The teams will then administer three interventions (neurofeedback, transcranial magnetic stimulation, and psilocybin assisted therapy), and repeat the tests above. A team with expertise in artificial intelligence will then use our data to try to find patterns that identify who is at high risk versus low risk with a high degree of accuracy.

Trial Details

NCT Number	NCT07484906
Lead Sponsor	University of New Mexico Collaborators: The Mind Research Network, Georgia State University, New Mexico VA Healthcare System, Washington University School of Medicine
Conditions	Suicidal Ideation
Start Date	2026-05-01
Primary Completion	2029-08-31 (estimated)
Study Completion	2029-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-20